Cetuximab Rechallenge and Monotherapy in Patients with Squamous Cell Carcinoma of the Head and Neck

By  

Case Reports in Oncology, Vol. 8, Iss. 3, 2015-11 ,pp. : 503-508

Karger

Access to resources Recommend Favorite

Induction Chemotherapy with Docetaxel, Cisplatin and Capecitabine, Followed by Combined Cetuximab and Radiotherapy in Patients with Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck: A Phase I-II Study

By  

Oncology, Vol. 84, Iss. 4, 2013-02 ,pp. : 251-254

Karger

Access to resources Recommend Favorite

Indirect comparison of the efficacy of cetuximab and cisplatin in squamous cell carcinoma of the head and neck

By Levy Adrian R.   Johnston Karissa M.   Sambrook Jennifer   Donato Bonnie   Penrod John R.   Corral Mitra   Chasen Martin  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2253-2259

Informa Healthcare

Access to resources Recommend Favorite

Platinum‐based chemotherapy plus cetuximab first‐line for Asian patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Results of an open‐label, single‐arm, multicenter trial

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 8, 2015-08 ,pp. : 1081-1087

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase II Study of Cetuximab in Combination with Docetaxel in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck after Platinum-Containing Therapy: A Multicenter Study of the Arbeitsgemeinschaft Internistische Onkologie

By  

Oncology, Vol. 84, Iss. 5, 2013-02 ,pp. : 284-289

Karger

Access to resources Recommend Favorite